TuHURA Biosciences Inc. Live Stock Price Today, Share Analysis and Chart

Name: TuHURA Biosciences Inc.: Is Infosys Ltd. worth buying?
Item: TuHURA Biosciences Inc.
Rating: 1.04641675
Author: Trendlyne DVM scores

about

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development p...

2.68 -0.10 (-3.60%)

68.98% Fall from 52W High

164.7K

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

2.2 / 100

Technically Neutral

39.7 / 100

No estimates available

TuHURA Biosciences Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

TuHURA Biosciences Inc. Live Stock Price Today, Share Analysis and Chart

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development p...

68.98% Fall from 52W High

SWOT Analysis

TuHURA Biosciences Inc. Live Price Chart